Image

End-of-life Decision-making Among Young Patients With Advanced Cancer: a Grounded Theory Approach

End-of-life Decision-making Among Young Patients With Advanced Cancer: a Grounded Theory Approach

Recruiting
18-39 years
All
Phase N/A

Powered by AI

Overview

The purpose of this qualitative research is to use grounded theory to explore and describe the thoughts of young advanced cancer patients regarding end-of-life care and how these thoughts influence the related decision-making process.

Eligibility

Inclusion Criteria:

  • The patient has a solid tumor.
  • The age at initial cancer diagnosis is between 15 and 39 years.
  • The patient is at least 18 years old at the time of enrollment.
  • The patient has cancer with metastasis, either present at initial diagnosis or occurring after treatment or follow-up.
  • After metastasis, the first-line curative treatment is ineffective.

Exclusion Criteria:

  • Patients who, for any reason, including severe psychological distress (as determined by the attending physician, psychiatrist, or specialist nurse based on assessments and impressions during routine patient care), cognitive impairment, or physical limitations (such as frailty), are unable to communicate or participate in an interview lasting more than 30 minutes.

Study details
    End-of-life Decision-making

NCT06551831

National Taiwan University Hospital

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.